PROSPECTIVE MULTICENTER STUDY OF RISK-FACTORS ASSOCIATED WITH DELAYED HEALING OF RECURRENT DUODENAL-ULCERS (RUDER)

被引:13
作者
ARMSTRONG, D
ARNOLD, R
CLASSEN, M
FISCHER, M
GOEBELL, H
BLUM, AL
机构
[1] PMU, CHUV, DIV GASTROENTEROL, LAUSANNE, SWITZERLAND
[2] UNIV MARBURG, DEPT INTERNAL MED, W-3550 MARBURG, GERMANY
[3] TECH UNIV MUNICH, DEPT GASTROENTEROL, W-8000 MUNICH 2, GERMANY
[4] INST NUMER STAT, COLOGNE, GERMANY
[5] UNIV ESSEN GESAMTHSCH, DIV GASTROENTEROL, W-4300 ESSEN 1, GERMANY
关键词
D O I
10.1136/gut.34.10.1319
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Risk factors for delayed duodenal ulcer healing during treatment with ranitidine (300 mg daily) were examined in a multicentre German study of 1923 patients with endoscopically proved, recurrent duodenal ulceration. Heating rates, per protocol, were 39-5% at two weeks, 70.9% at four weeks, and 93.2% at eight weeks. Prospective testing of five, predefined risk factors indicated that smoking (p=0.0039) was associated with a decreased heating rate at two weeks. Frequent prior recurrence (p=0.464), a heavy physical workload (p=0.145), and psychological stress (p=0.062) were not associated with a decreased healing rate and there were too few patients at risk to allow assessment of the effect of regular NSAID intake. Exploratory analysis identified prior slow healing, a large ulcer, multiple ulcers, and prior ulcer complications, in addition to smoking, as markers of slow healing. In the absence of these risk factors, the mean healing time was 3.3 weeks (95% confidence interval 3.0, 3.5), rising to 3.7 weeks (3.5, 3.9) for one, 4.4 weeks (4.1, 4.7) for two, and 5.1 weeks (4.5, 5.6) for three to five risk factors. Delayed duodenal ulcer healing is associated with multiple factors whose effect is cumulative; for patients with two or more of five easily identified risk factors, more than four weeks' treatment with a histamine H-2 receptor antagonist is required to achieve ulcer healing.
引用
收藏
页码:1319 / 1326
页数:8
相关论文
共 38 条
  • [1] ANDREOLI TE, 1986, CECIL ESSENTIALS MED, P293
  • [2] REFRACTORY DUODENAL-ULCER
    BARDHAN, KD
    [J]. GUT, 1984, 25 (07) : 711 - 717
  • [3] BATTAGLIA G, 1985, ITAL J GASTROENTEROL, V17, P262
  • [4] DOES SMOKING INTERFERE WITH THE EFFECT OF HISTAMINE H-2-RECEPTOR ANTAGONISTS ON INTRAGASTRIC ACIDITY IN MAN
    BAUERFEIND, P
    CILLUFFO, T
    FIMMEL, CJ
    EMDE, C
    VONRITTER, C
    KOHLER, W
    GUGLER, R
    GASSER, T
    BLUM, AL
    [J]. GUT, 1987, 28 (05) : 549 - 556
  • [5] PRESENTING CHARACTERISTICS OF PATIENTS WITH DUODENAL-ULCER AND OUTCOME OF MEDICAL-TREATMENT IN CONTROLLED CLINICAL-TRIALS USING CIMETIDINE AND DIETHYLAMINE PERSILATE TO TREAT ULCER ATTACK AND DIETHYLAMINE PERSILATE AND PLACEBO TO PREVENT RELAPSESE
    BERTSCHINGER, P
    LACHER, G
    AENISHANSLIN, W
    BAERLOCHER, C
    BERNOULLI, R
    EGGER, G
    EISNER, M
    FASEL, F
    FEHR, HR
    FUMAGALLI, I
    GASSMANN, R
    GULLER, R
    KOBLER, E
    LEUTHOLD, E
    NUESCH, HJ
    PACE, F
    PELLONI, S
    PLANCHEREL, P
    REALINI, S
    SEILER, P
    STOCKER, H
    VETTER, D
    SCHMID, P
    SIMONIAN, B
    VOGEL, E
    BLUM, AL
    [J]. DIGESTION, 1987, 36 (03) : 148 - 161
  • [6] BLUM A L, 1990, Gastroenterology, V98, pA22
  • [7] TREATMENT OF DUODENAL-ULCER WITH PIRENZEPINE AND CIMETIDINE
    BRUNNER, H
    DITTRICH, H
    KRATOCHVIL, P
    BRANDSTATTER, G
    HENTSCHEL, E
    SCHUTZE, K
    TRAGL, KH
    KERN, H
    LOFFELMANN, K
    ZEILER, H
    CZITOBER, H
    PUBLIG, W
    ZANDL, C
    WEISS, W
    RUDIGER, E
    POTZI, R
    LOCHS, H
    POLTERAUER, P
    REICHEL, W
    KERSTAN, E
    BAUER, P
    [J]. GUT, 1984, 25 (02) : 206 - 210
  • [8] ABO BLOOD GROUPS AND SECRETOR CHARACTER IN DUODENAL ULCER - POPULATION AND SIBSHIP STUDIES
    CLARKE, CA
    EDWARDS, JW
    HADDOCK, DRW
    HOWELEVANS, AW
    MCCONNELL, RB
    SHEPPARD, PM
    [J]. BRITISH MEDICAL JOURNAL, 1956, 2 (SEP29) : 725 - 731
  • [9] COLINJONES DG, 1987, DISEASE GUT PANCREAS, P288
  • [10] FLEISS JL, 1982, STATISTICAL METHODS, P56